Overview
Protein motion-based drug discovery using ML and physics simulation.
Details
Relay (Nasdaq: RLAY) targets allosteric and motion-driven drug design with its Dynamo platform. Programs in oncology and rare disease.
Relay Therapeutics
Protein motion-based drug discovery using ML and physics simulation. Relay (Nasdaq: RLAY) targets allosteric and motion-driven drug design with its Dynamo platform. Programs in oncology and rare disease.